EFFECT ·Filed May 8, 2026

ONCO

Onconetix, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed4mo ago SEC9999999995-26-001545
IPO/offering going effective
Actionable Insight ▼ Bearish

Expect heavy selling pressure as Keystone begins distributing shares. The stock is likely to decline further given the extreme dilution relative to market cap. Avoid long positions and monitor volume for signs of accelerated distribution. The ELOC structure allows the company to continue drawing capital, but each draw adds more shares to the resale pool.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
ONCO ▼ -78.04% at T+60d
SHORT call ✓ call won +78.04% · α vs SPY +82.88% · entry $3.80 → $0.8346
Entry anchored
May 8, 2026
via day open
T+1d
+5.82%
call -5.82% · α -5.58%
$4.02
settled 5mo ago
T+5d
-1.58%
call +1.58% · α +1.79%
$3.74
settled 5mo ago
T+20d
-72.89%
call +72.89% · α +72.92%
$1.03
settled 4mo ago
T+60d
-78.04%
call +78.04% · α +82.88%
$0.8346
settled 8w ago

Price Chart

Loading chart...

Executive Summary

The SEC declared effective Onconetix's S-1 registration (File No. 333-295376), enabling Keystone Capital Partners to immediately resell up to 25 million shares into the market under the existing ELOC Purchase Agreement. At recent prices, this represents roughly 5x the company's $5M market cap, creating severe dilution overhang and imminent selling pressure.

Key Facts

  • EFFECT notice filed 2026-05-07 for S-1 registration covering up to 25,000,000 shares held by Keystone Capital Partners.
  • Registered shares represent approximately 5x Onconetix's current $5M market cap at the last reported price of $0.5880 per share.
  • Keystone can now immediately sell shares into the market; the company receives no proceeds from resales but may draw up to $25M from future ELOC purchases.
  • Onconetix has already sold ~701,933 split-adjusted shares under the ELOC for $8.1M in aggregate proceeds through April 24, 2026.

Financial Impact

Potential selling of up to 25M shares (worth ~$14.7M at recent prices) against a $5M market cap, implying massive dilution and downward price pressure.

dilutionstock pricemarket capitalization

Risk Factors

  • Immediate dilution from resale of up to 25M registered shares by Keystone.
  • Low liquidity and $5M market cap amplify price impact of any selling.
  • Potential for accelerated selling if Keystone seeks to exit quickly.
  • Further dilution if Onconetix elects additional ELOC draws, adding more shares to the resale registration.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001545
Document: 9999999995-26-001545-index.html9999999995-26-001545
Document: 9999999995-26-001545.txt9999999995-26-001545
22 reports for ONCO
Performance horizon
64% Hit rate 7 of 11 directional calls best @ T+5▲ +37.51%Sep 4, 2026
Filters
Rows
Reports for ONCO — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
DEFA14A / 8-K
NEUTRAL ★ 4/10
$0.6374 $0.6549▲ +2.75%▲ +2.64%$0.7440 (+16.72%)
Sep 14, 2026
18d ago
8-K
BEARISH ★ 6/10
$0.6374 $0.6549▼ −2.75%▼ −2.64%$0.7440 (−16.72%)
Sep 14, 2026
18d ago
425
BEARISH ★ 6/10
$0.6374 $0.6549▼ −2.75%▼ −2.64%$0.7440 (−16.72%)
Sep 4, 2026
28d ago
EFFECT
BEARISH ★ 8/10
$1.02 $0.6374▲ +37.51%▲ +36.30%$0.7440 (+27.06%)
Sep 3, 2026
29d ago
425
NEUTRAL ★ 3/10
$0.7390 $0.7564▲ +2.35%▲ +3.50%$0.7440 (+0.68%)
Aug 31, 2026
4w ago
S-1/A
BEARISH ★ 8/10
$0.6528 $0.8132▼ −24.57%▼ −24.49%$0.7440 (−13.97%)
Aug 12, 2026
7w ago
S-1
BEARISH ★ 8/10
$0.8920 $0.7110▲ +20.29%▲ +19.85%$0.7440 (+16.59%)
Jul 29, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.7864 $0.9037▼ −14.92%▼ −11.29%$0.7440 (+5.39%)
Jul 7, 2026
12w ago
425
NEUTRAL ★ 2/10
$1.07 $0.8487▼ −20.68%▼ −21.23%$0.7440 (−30.47%)
Jun 17, 2026
15w ago
EFFECT
BEARISH ★ 6/10
$0.9949 $1.00▼ −0.51%▼ −1.55%$0.7440 (+25.22%)
Showing 10 of 22

US Market Status

Market Closed — Opens Mon (37h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access